The translocator protein (TSPO) is an outer mitochondrial membrane protein involved in the transport of cholesterol into the mitochondria, which is the first step for the synthesis of steroid hormones, as well as in the regulation of mitochondrial permeability transition pore opening and apoptosis. Studies have shown that the activation of TSPO may promote neuroprotective actions in experimental models of neurodegeneration and brain injury. In a previous study, our group showed that 4′-chlorodiazepam (4′-CD), a TSPO ligand, was neuroprotective against amyloid-beta (Aβ) in SHSY-5Y neuroblastoma cells. The aim of this study was to evaluate if 4′-CD was also neuroprotective against Aβ in organotypic hippocampal cultures and to identify its mechanisms of action. Aβ decreased the cell viability of organotypic hippocampal cultures, while 4′-CD had a neuroprotective effect when administered at 100 nM and 1000 nM. The neuroprotective effects of 4′-CD against Aβ were associated with an increased expression of superoxide dismutase (SOD). No differences were found in the expression of catalase, glial fibrillary acidic protein, Akt and procaspase-3. In summary, our results show that 4′-CD is neuroprotective against Aβ by a mechanism involving the modulation of SOD protein expression.
Introduction
The increase in the life expectancy of the world population is followed by an exponential increase in the number of people affected by aging-related neurodegenerative diseases. Alzheimer's disease (AD) is the most common neurodegenerative disease and the major cause of dementia in people over 60 years-old, affecting around 35 million people over the world [1] . Data from 2013 show that whereas the mortality rate related to cardiovascular diseases and stroke decreased by 14% and 23%, respectively, the mortality rate related to AD increased by 71% in comparison with data from 2000, making it the sixth leading cause of death in the USA and the fifth leading cause of death in individuals over 65 years-old [2] . The costs related to the treatment and care of patients with dementia in the USA in 2016 were estimated in 236 billion dollars [2] , while the expenses related to the care of patients suffering from dementia in Europe were estimated in 105 billion euros in 2010 [3] . However, despite the large economic impact of AD and its impact on the health and life quality of patients, there are no effective treatments for this disease. Currently, the drugs approved for the treatment of AD are only intended to treat some of the symptoms of this disease, and there is no treatment able to prevent its progression through the inhibition of its pathogenic mechanisms [4] . AD pathology is characterized by the presence of intracellular neurofibrillary tangles composed by hyper-phosphorylated aggregates of tau and extracellular senile plaques mainly formed by amyloid-beta (Aβ) peptide [5] . The accumulation of Aβ leads to increased astrogliosis [6] and causes neuronal damage through the activation of proapoptotic pathways [7] [8] [9] , besides contributing to the formation of intracellular neurofibrillary tangles, accelerating neuronal death and leading to dementia [10] . In addition, AD is also related to oxidative stress, represented by lipid peroxidation and protein and DNA oxidation [11] . Aβ accumulation has been associated with increased levels of reactive oxygen species (ROS) and decreased levels and activities of antioxidant enzymes, including superoxide dismutase (SOD), catalase and glutathione peroxidase .
The translocator protein (TSPO) is an outer mitochondrial membrane protein that presents a high-affinity for cholesterol due to the presence of a cholesterol recognition amino acid consensus (CRAC) domain at its C-terminal extremity [15, 16] . Functionally, this protein is thought to mediate the cholesterol transport inside the mitochondria, which is the rate-limiting step in the biosynthesis of steroid hormones. Steroidogenesis starts in the mitochondria, with the production of pregnenolone after the cleavage of cholesterol side chain by the cytochrome P450 side chain cleavage enzyme (CYP11A1), and continues in the endoplasmic reticulum, where pregnenolone is transformed into the final steroid products, such as estradiol, progesterone and testosterone [17, 18] . In addition to the regulation of steroidogenesis, TSPO has been also associated with the control of other mitochondrial functions, including cell proliferation and differentiation, mitochondrial respiration and with the regulation of the opening of the mitochondrial permeability transition pore (MPTP), thereby controlling cytochrome C release, caspase activation and apoptosis [19] [20] [21] [22] [23] .
Studies have shown that TSPO ligands present neuroprotective actions in experimental models of brain injury and neurodegenerative diseases (see Arbo et al. [24] for review). Specifically regarding AD, it was observed that 4′-CD was neuroprotective in a mouse model of AD represented by the use of 3xTgAD mice, decreasing hippocampal accumulation of Aβ and gliosis and improving the functional outcomes of the animals [25] . In addition, a previous study of our group showed that 4′-CD is neuroprotective against Aβ administration in SH-SY5Y neuroblastoma cells through the modulation of the protein expression of survivin and Bax [26] . It is known, however, that the use of cell lines presents some limitations in comparison with in vivo experimental models, including, for example, the presence of a single cell type in the cultures and the absence of the cell arrangement and organization that characterizes the brain tissue. Therefore, due to the need to study if 4′-CD were also neuroprotective against Aβ-induced neurotoxicity in experimental models which may be a better representation of the in vivo brain, presenting different cell types and the typical cell arrangement from the brain tissue, the aim of this study was to investigate the neuroprotective effects of 4′-CD against Aβ in organotypic hippocampal cultures and its mechanisms of action.
Material and methods

Chemicals
Dimethyl sulfoxide (DMSO), 4′-CD and propidium iodide (PI) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Culture mediums were purchased from Gibco (Carlsbad, CA, USA). Aβ was supplied by Bachem (Bubendorf, Switzerland). Antibodies were purchased from Santa Cruz (Santa Cruz, CA, USA), except where indicated.
Organotypic hippocampal cultures
Hippocampal slice cultures were obtained from 8-day-old male Wistar rats as previously described [27] . Briefly, the animals were euthanized, their brains were removed, the hippocampi were dissected and transverse hippocampal slices (400 μm thickness) were obtained by using a McIlwain tissue chopper (Mickle Laboratory Engineering Co., Guilford, UK). The slices were placed on membrane inserts (Millicell ® -CM 0.4 μm, Millipore) in six-well plates. Each well contained 1 ml of culture medium consisting of 50% minimum essential medium (MEM), 25% Hank's balanced salt solution (HBSS), 25% horse serum supplemented with glucose (36 mM), HEPES (25 mM), NaHCO 3 (4 mM), fungizone (1%) and gentamicin 0.100 mg ml −1 . Cultures were incubated at 37°C in an atmosphere of 5% of CO 2 for 25 days in vitro (DIV) prior to use. Culture medium was changed twice a week.
Drugs and treatments
4′-CD was dissolved in DMSO and stored at −20°C until use. Aβ 1-42 was incubated in Milli-Q water at 37°C for 72 h prior to use. On DIV 25, cultures were treated with Aβ 1-42 (5 μM) plus 4′CD in three different doses (10 nM, 100 nM and 1 μM) or its vehicle for 72 h.
Quantification of cellular death
Cell damage was evaluated by fluorescent image analysis of the incorporation of propidium iodide (PI) in the hippocampal slices. PI is a polar compound that penetrates only in damaged cell membranes of dying cells, binding to nuclear DNA and generating a bright red fluorescence. Seventy-one hours after treatments, the cultures were stained with PI (5 mM) for 1 h. PI fluorescence was observed by an inverted fluorescence microscope (Nikon Eclipse TE 300). Images were captured using a CCD camera (Visitron Systems, Puchheim, Germany) and subsequently analyzed using the software Scion Image. The incorporation of PI was determined densitometrically after transforming the red values into grey values. For quantification of cellular damage, the percentage of area stained with PI above background level was calculated in relation to the total area of each slice [27] . Data are presented as % of PI incorporation.
Western blot
Organotypic cultures were homogenized in lysis buffer containing 4% sodium dodecyl sulfate (SDS), 50 mM Tris, 2 mM EDTA, 1% mammalian protease inhibitor (Roche, San Francisco, CA, USA) at 4°C and stored at −20°C before use. Equal amounts of protein (50 μg) were resolved and immunodetected as previously described [28] . The membranes were processed for immunodetection using rabbit polyclonal antibodies for SOD1 (16 kDa) (1:500 dilution), catalase (64 kDa) (1:500 dilution), glial fibrillary acidic protein (GFAP) (1:2000 dilution) (50 kDa) (Sigma Aldrich), p-Akt (Ser473, 60 kDa) (1:500 dilution), Akt (60 kDa) (1:500 dilution) and procaspase-3 (32 kDa) (1:500 dilution). After washing with TTBS, the membranes were incubated at room temperature for 2 h with goat anti-rabbit or goat anti-mouse peroxidase-conjugated secondary antibodies (1:10,000 dilution) (Millipore, Billerica, MA, USA) and washed with TBS (20 mM Tris-HCl, 140 mM NaCl, pH = 7.4). The blots were revealed for chemiluminescence followed by apposition of the membranes to autoradiographic films (Hyperfilm ECL, Amersham). The films were scanned and the digitalized images analyzed using the software ImageJ (NIH, Bethesda, MD, USA). The results from each membrane were normalized to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (36 kDa) (1:500 dilution) (Millipore) or β-actin (43 kDa) (1:2000) (Sigma Aldrich). The average optical density for the control group was designated as 100%. Samples from all experimental groups were processed in parallel to minimize interassay variations. Protein expression values were represented as arbitrary densitometric units.
Statistical analysis
A one-way analysis of variance (one-way ANOVA) was performed to compare the cellular damage and the expression of different proteins between the experimental groups. When appropriate, ANOVA was followed by the Student-Newman-Keuls (SNK) post hoc test. All results were expressed as mean ± standard error (SEM) and were considered significantly different when P < 0.05. All the tests were performed using the software GraphPad Prism 5.0 software (La Jolla, CA, USA).
Results
4′-CD is neuroprotective against Aβ induced neurotoxicity
First, to establish a model of Aβ-induced neurotoxicity, we evaluated the effect of Aβ (5 μM) treatment for 24, 48 and 72 h in the viability of organotypic hippocampal cultures. It was observed that the administration of Aβ decreased the viability of hippocampal cultures after 72 h, while its administration for 24 or 48 h did not significantly affect the viability of the cultures (F (3,23) = 51.36, P < 0.0001) (Fig. 1A and B) . Based on these results, we selected to use the Aβ at the dose of 5 μM for 72 h in the other experiments. Later, we evaluated if 4′-CD was neuroprotective against Aβ administration for 72 h in rat organotypic hippocampal cultures. It was observed that 4′-CD was neuroprotective against Aβ when administered at 100 nM or 1 μM (F (5,48) = 61.24, P < 0.0001) (Fig. 1C and D) .
The neuroprotective effects of 4′-CD against Aβ could be related with the modulation of the protein expression of SOD
After showing that 4′-CD was neuroprotective against Aβ-induced neurotoxicity in organotypic hippocampal cultures, we studied the expression of some proteins related to the control of cell survival and apoptosis, including SOD1, Akt and procaspase-3, that could be mediating the neuroprotective actions of 4′-CD. It was observed that the administration of 4′-CD in all the concentrations tested increased the protein expression of SOD1 after the administration of Aβ (F (5,53) = 3.228, P = 0.0136) (Fig. 2) . No differences were found in the protein expression of catalase (Fig. 3) , GFAP (Fig. 4) , phosphorylated Akt in Ser473 (Fig. 5 ) and procaspase-3 (Fig. 6) between the experimental groups.
Discussion
In the last decade, several studies have investigated the use of TSPO ligands as neuroprotective agents in experimental models of brain injury and neurodegenerative diseases [24] . Specifically, regarding the neuroprotective effects of TSPO ligands in experimental models of AD, a previous study by our group showed that 4′-CD is neuroprotective against Aβ in SH-SY5Y neuroblastoma cells [26] . Corroborating these data, in this study, we showed that 4′-CD was neuroprotective against Aβ in organotypic hippocampal cultures. Since glial cells could be an important site for the action of TSPO ligands as TSPO expression is Fig. 1 . Effect of different doses of 4′-CD in the viability of rat organotypic hippocampal slices exposed to Aβ. First, to establish a model of Aβ-induced neurotoxicity, we evaluated the effect of Aβ (5 μM) treatment for 24, 48 and 72 h in the viability of organotypic hippocampal slices. It was observed that the administration of Aβ decreased the viability of hippocampal slices after 72 h, while its administration for 24 or 48 h did not affect the viability of the slices (Panels A and B) (***Different from control group, ANOVA/SNK, P < 0.001) (n = 3-12/ group). Later, we evaluated if 4′-CD was neuroprotective against Aβ administration for 72 h in rat organotypic hippocampal slices. Cultures were treated with vehicle or 4′-CD (10 nM, 100 nM and 1 μM) and exposed to Aβ (1-42) (5 μM) for 72 h (Panels C and D) (#Different from control group; *** Different from Aβ group, ANOVA/SNK, P < 0.001) (n = 9). Data represent the mean ± SEM for the PI incorporation. 
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Fig . 3 . Effect of 4′-CD in the protein expression of catalase in organotypic hippocampal slices exposed to Aβ. Cultures were treated with vehicle or 4′-CD (10 nM, 100 nM and 1 μM) and exposed to Aβ (1-42) (5 μM) for 72 h. Data represent the mean ± SEM (n = 4-6/group). generally higher in these cells than in neurons [29, 30] , we chose to study the neuroprotective effects of 4′-CD against Aβ in organotypic hippocampal cultures, as they preserve the connections between neurons and glial cells and could help us to better understand the mechanisms involved in the neuroprotective actions of 4′-CD against Aβ-induced neurotoxicity. It is known that AD is associated with oxidative damage and that Aβ accumulation has been associated with increased levels of reactive oxygen species (ROS) and decreased levels and activities of antioxidant enzymes, including SOD, catalase and glutathione peroxidase [12] [13] [14] . Here, we showed that the treatment with 4′-CD after Aβ administration was able to increase the expression of SOD1 in comparison with the Aβ-only treated group. SOD is an enzyme that catalyzes the dismutation of the superoxide radical, which is produced as a by-product of the oxygen metabolism and may cause many types of cell damage [31] . Oxidative stress that occurs within the bilayer, postulated in the Aβ-induced oxidative stress hypothesis in which Aβ 1-42 inserts as oligomers into the bilayer and serves as a source of ROS, has been shown to initiate lipid peroxidation [11] . Studies show that Met-35 of Aβ peptides is critical for Aβ-associated toxicity and oxidative stress. The oxidation of Met-35 to form methionine sulfoxide plays an important role in the regulation of protein function and cellular defense, and may lead to lipid or protein oxidation [32, 11] . Studies have reported increased levels of oxidative stress markers for protein oxidation/nitration and nucleic acid oxidation in brains from patients in the early stages of AD [33] [34] [35] [36] . In addition, Murakami et al. [37] have shown that SOD1 deficiency drives Aβ oligomerization and memory loss in a mouse model of AD, while other study showed that human neuroblastoma SH-SY5Y cells overexpressing SOD1 are less susceptible to Aβ insult [38] , corroborating the idea that SOD could have a crucial role in the defense against Aβ-induced damage. Therefore, the stimulation of the synthesis and activity of antioxidant enzymes could be a mechanism for the action of neuroprotective agents against Aβ-induced neurotoxicity. Indeed, several studies have shown that the neuroprotective actions of different compounds against Aβ involve the modulation of the expression of antioxidant enzymes in brain cells [13, 39, 14] . Moreover, some studies have shown that 4′-CD exerts antioxidant effects in different experimental models. Mehta et al. [40] showed that 4′-CD attenuates the cognitive impairment promoted by the administration of a carbamate pesticide through an increase in the expression of antioxidant enzymes. In addition, other authors have also associated the antioxidant effects of 4′-CD with its cardioprotective effects in different experimental models [41] [42] [43] . On the other hand, although 4′-CD administration was able to increase SOD protein expression, it did not change the protein expression of catalase, which is an intracellular enzyme that catalyzes the decomposition of hydrogen peroxide to water and oxygen [44] . Therefore, all together, these data suggest that the modulation of SOD protein expression could be related with the neuroprotective actions of 4′-CD against Aβ-induced neurotoxicity.
In addition to its oxidative damage, it is known that Aβ may affect neuronal survival by inducing neuroinflammation and astrogliosis [45, 6] . Astrogliosis is characterized by increased expression of GFAP and other intermediate filament proteins and by changes in astrocyte morphology and function [46] . Astrocytes are one of the most abundant cell types in the mammalian brain and are involved with several functions, including synapse formation, energetic and redox metabolism, synapse homeostasis of neurotransmitters and ions and synaptic information storage and transfer [47, 48] . GFAP is the main intermediate filament protein in astrocytes, and have been widely used as a marker for astrocytes, known to be induced upon neuroinflammation and brain damage [47] . Although other studies have associated Aβ induced neurotoxicity with increased astrogliosis [49, 6] , we did not observe significant differences in the expression of GFAP between the experimental groups. It is important to mention, however, that the expression of GFAP was evaluated 72 h after Aβ administration, while the peak of reactive gliosis, astrocyte proliferation and GFAP expression after an acute stimulus may happen approximately 1 week after injury [50] . Indeed, using another model of neurodegeneration represented by the administration of lysolecithin, other authors have shown that GFAP expression does not change after 2 days of injury, although there is an increase in the expression of this protein 5 days after lesion [51] . Therefore, it is possible that we could have observed differences in the expression of GFAP if we analyzed its expression in a longer time point after injury, and it is impossible to rule out the involvement of neuroinflammation in the effects caused by Aβ. Also, the absence of differences in the expression of GFAP may indicate that there is an equal number of astrocytes between the groups, and that the cells that are more susceptible to the toxic effects of Aβ are neurons.
Aβ is also able to cause neuronal damage through the modulation of the balance between pro-and anti-apoptotic proteins [52, 27, 26] . Therefore, we studied the expression of some proteins involved in the regulation of cell survival to verify their involvement in the neuroprotective effects of 4′-CD against Aβ-induced neurotoxicity. In this study, we did not find any difference in the phosphorylation of Akt and the expression of procaspase-3 between our experimental groups. Akt is a serine/threonine kinase which is part of the phosphoinositide-3 kinase (PI3K) pro-survival pathway. Although previous studies showed that Akt may be involved in the Aβ-induced cell damage [53, 54] , Hoppe et al. [27] did not show any difference in the phosphorylation of Akt after Aβ administration in rat organotypical hippocampal slices in a protocol similar to that used in this paper. However, we cannot rule out the involvement of PI3K/Akt pathway in the effects of both Aβ of 4′-CD in this experimental model, as changes in the expression and activation of Akt could be happening in the first hours after treatments, but could be abolished after 72 h. In addition to the absence of differences in Akt expression, we did not find any difference in the expression of procaspase-3 in our experimental groups. Procaspase-3 is the inactive precursor of caspase-3, which is considered the central and final apoptotic effector responsible for apoptosis. Previous studies have suggested that Aβ neurotoxicity may not be related to caspase activation [55] [56] [57] [58] . In addition, another recent study from our group showed that the neuroprotective effects of 4′-CD against Aβ in SH-SY5Y cells do not involve the regulation of the expression of procaspase-3 [26] . Therefore, our data corroborate previous studies and indicate that Aβ-induced neurotoxicity may be caspase-independent.
As previously mentioned, TSPO is thought to regulate the transport of cholesterol inside the mitochondria, thereby regulating steroidogenesis [59, 24] . Thus, one of the hypothesis for the explanation of the neuroprotective actions of TSPO ligands against Aβ is that the activation of this protein could be associated with increased neurosteroidogenesis, and that these neurosteroids could be mediating the neuroprotective actions of TSPO ligands. Into this context, it is known that some steroid hormones are neuroprotective against Aβ in different experimental models and modulate oxidative stress in AD. Studies show that estradiol is neuroprotective against Aβ in SH-SY5Y cells and hippocampal neurons, decreasing ROS levels, lipid peroxidation and oxidative injury after Aβ administration [60, 61] . In addition, Qian et al. [62] showed that allopregnanolone attenuates Aβ-induced neurotoxicity in PC12 cells by reducing the intracellular ROS generation and lipid peroxidation and increasing the SOD activity. These data are corroborated by other studies showing that neuroactive steroids are able to exert antioxidant effects in the brain in different experimental conditions [63] [64] [65] . Therefore, as 4′-CD exert neuroprotective effects against Aβ through mechanisms of action that are similar to those used by neurosteroids in this same context, including the modulation of the brain redox status and the activity of antioxidant enzymes, it is possible that these effects could be mediated by the increased biosynthesis of neurosteroids, and this hypothesis should be tested by further studies.
In summary, our findings indicate that 4′-CD is neuroprotective against Aβ-induced neurotoxicity by a mechanism involving the regulation of SOD protein expression. Further studies may evaluate if the neuroprotective actions of 4′-CD against Aβ are mediated by increased neurosteroids biosynthesis related to the stimulation of TSPO activity and if they involve the modulation of other oxidative stress parameters.
